C1GALT1 and gastric cancer: In gastric cancer AGS cells, suppression of C1GalT1 expression altered EphA2 O-glycosylation and reduced the EphA2 binding by its ligand Ephrin A1, resulting in deceased EphA2 phosphorylation and reduced cell migration and invasion [28].